Rare diseases
Investigational molecules
Locations
Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors
FranceStudy on Vedolizumab and Ustekinumab for Patients with Crohn's Disease and Ulcerative Colitis
DenmarkLong-term Follow-up Study for Patients with Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma Treated with OC-1 Cells
SpainStudy on the Safety of Eganelisib Alone and with Cytarabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndromes
SpainStudy on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant
GermanyStudy on the Effects of TRI-001 for Patients with Chronic Limb Threatening Ischemia Due to Peripheral Arterial Disease
GermanyStudy on MaaT033 and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-1/PD-L1 Blockade Due to Antibiotic Use
FranceStudy of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation
FranceStudy on Preoperative Antibiotics for Patients with Acute Cholecystitis: Comparing Ertapenem, Ciprofloxacin, and Cefuroxime
FinlandStudy on Dapagliflozin, Finerenone, and Semaglutide for Treating Chronic Kidney Disease in Patients
DenmarkStudy Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide
AustriaStudy of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
